Human Dermal Fibroblasts-fetal (HDF-f)

Cat.No.: CSC-7797W

Species: Human

Source: Dermis

Cell Type: Fibroblast

  • Specification
  • Background
  • Scientific Data
  • Q & A
  • Customer Review
Cat.No.
CSC-7797W
Description
Fibroblasts are mesenchymal cells derived from the embryonic mesoderm. They have been extensively used for a wide range of cellular and molecular studies. This is mainly because they are one of easiest types of cells to grow in culture, and their durability makes them amenable to a wide variety of manipulations ranging from studies employing gene transfection to microinjection. There is good evidence that fibroblasts in different parts of the body are intrinsically different. Fibroblasts within tissues are exposed to a dynamic mechnical environment, which influences the structure integrity of both healthy and healing soft tissue. Fibroblasts secrete a nonrigid extracellular matrix that is rich in type I and/or type III collagen. In addition, dermal fibroblasts also secrete large quantities of hyaluronan in response to inflammatory stimuli. During wound healing, dermal fibroblasts switch from a migratory, repopulating phenotype to a contractile, matrix-reassembling phenotype.HDF from Bioarray Research Laboratories are isolated from fetal human skin. HDF are cryopreserved at primary culture and delivered frozen. Each vial contains >5 x 10^5 cells in 1 ml volume. HDF are characterized by their spindle morphology and immunofluorescent method with antibody to fibronectin. HDF are negative for HIV-1, HBV, HCV, mycoplasma, bacteria, yeast and fungi. HDF are guaranteed to further expand for 15 population doublings at the condition provided by Bioarray Research Laboratories.
Species
Human
Source
Dermis
Cell Type
Fibroblast
Disease
Normal
Storage and Shipping
Directly and immediately transfer cells from dry ice to liquid nitrogen upon receiving and keep the cells in liquid nitrogen until cell culture needed for experiments.
Citation Guidance
If you use this products in your scientific publication, it should be cited in the publication as: Creative Bioarray cat no. If your paper has been published, please click here to submit the PubMed ID of your paper to get a coupon.

Human dermal fibroblasts- fetal (HDF-f) are isolated from fetal dermal tissue and represent the most prevalent cell type within the loose connective tissue. These cells are typically located in close proximity to collagen fibers, to which they attach. Morphologically, they exhibit an elongated spindle shape and contain a cytoplasm rich in basophilic granules. Notably, their surface expresses high-affinity FcεRI receptors that bind free IgE, implicating them in type I hypersensitivity reactions. HDF-f are critical for the formation and development of fetal connective tissue, playing an indispensable role in embryonic development. HDF-f demonstrate a high proliferative capacity and vigorous metabolism, making them particularly amenable to in vitro culture and successive passaging.

The primary function of HDF-f is to synthesize and secrete extracellular matrix components such as collagen and elastin, which are crucial for maintaining skin firmness, elasticity, and moisture. Upon skin injury, these fibroblasts proliferate and migrate to the wound site, actively participating in the repair and regeneration process through the synthesis and secretion of matrix components. This capability is vital for preserving the integrity and function of fetal skin. Due to their developmental stage, HDF-f exhibit greater plasticity and possess a distinct gene expression profile compared to adult fibroblasts. Consequently, HDF-f hold significant potential for applications in tissue engineering and regenerative medicine, particularly given their enhanced capacity for regeneration and plasticity.

The morphology of fetal dermal fibroblasts was observed under a 40X inverted light microscope.Fig. 1. 40X Inverted light microscopy of fetal dermal fibroblasts morphology (Goodarzi P, Falahzadeh K, et al., 2018).

hFDFs Exhibit In Vitro Multipotency and Displays an MSC Phenotype.

Developing allogeneic cell therapies that do not depend on large donor areas shows promise in addressing chronic and acute skin wound healing. Human fetal-derived dermal fibroblasts (hFDFs) are of particular interest due to their high division rates, low immunological rejection, and scarless healing ability. Esteban-Vives's team examined the potential of hFDFs as a source for cell banking.

Results indicated that hFDFs share markers and differentiation capabilities with bone marrow-derived mesenchymal stem cells (MSCs), demonstrating therapeutic potential. The hFDF cell populations demonstrated in vitro multipotency, similar to human MSCs. Proteoglycan staining post-induction confirmed osteogenic, adipogenic, and chondrogenic differentiation (Fig. 1A). hFDFs from six donors were cultured up to three passages, showing a decrease in CD105/CD90/CD73 expression from 57% to 15%, and an increase in CD34/CD45/CD14 expression from 0.1% to 2.6% by passage 3, maintaining CD79a/HLA-DR below 0.1% (Fig. 1B). Gene expression analysis from passages 4 to 7 corroborated these trends (Fig. 1C). Although hFDFs showed no significant growth rate differences compared to MSC-sorted hFDFs, their division rate was higher than BM-MSCs, suggesting suitability for cell banking (Fig. 1D).

Identification of mesenchymal stem cell (MSC) populations within human fetal dermal-derived fibroblasts (hFDFs).Fig. 1. Detection of mesenchymal stem cell (MSC) population in human fetal dermal-derived fibroblasts (hFDFs) (Esteban-Vives R, Ziembicki J, et al., 2019).

Traction Forces Lower in Fetal Dermal Fibroblasts Than Adult

During adult wound healing, fibroblasts transition into myofibroblasts, generating forces that lead to scar formation. However, fetal wounds, which contain less transforming growth factor-ß1 and are softer, heal without scarring. Thus, Rachel's team explored whether the unique contractile behavior of fetal fibroblasts contributes to scarless repair.

Rachel's team tested whether physiological wound rigidity induces contractile forces in fetal dermal fibroblasts. Their previous work suggests that fetal fibroblasts have altered responses to ECM mechanical cues; therefore, they tested whether mechanosensing by adult and fetal dermal fibroblasts is differentially regulated by ECM rigidity. Fibroblasts were cultured on fibronectin-conjugated soft, hard, and rigid PAAs, corresponding to various wound healing stages, to measure contractile force generation (Fig. 2A). Both cell types showed similar force generation on soft and hard PAAs, but adult dermal fibroblasts exerted more force on rigid PAAs (Fig. 2B-C). This difference persisted after 18 hours (Fig. 2A-C). Using traction force microscopy, they once again found that adult dermal fibroblasts exerted larger traction forces than fetal dermal fibroblasts on rigid PAAs even though their cell sizes were the same (Fig. 2D-F). The results showed that traction forces were higher in adult dermal fibroblasts than in fetal ones after incubation.

On rigid ECM, fetal dermal fibroblasts generate less contractile force compared to adult dermal fibroblasts.Fig. 2. Fetal dermal fibroblasts exert less contractile force than adult dermal fibroblasts on rigid ECM (Rachel J., Jerrell, BS., et al., 2018).

Ask a Question

Write your own review

For research use only. Not for any other purpose.